Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Phase II, Multicenter, Randomized, Open-Label, Controlled Study of M7824 Versus Pembrolizumab as a First-line Treatment in Patients With PD-L1 Expressing Advanced Non-small Cell Lung Cancer https://www.kusajili.fr:443/Trial/ufd9B9yR1Uq_AzhteZOiOQ%24a-phase-ii-multicenter-randomized-open-label-controlled-study-of-m7824-versus-pembrolizumab-as-a-first-line-treatment-in-patien
I have read and accept the terms of use of the site and the Privacy Policy
Send your message